That is actually a good point. It would be interesting to know what the competition for Alcidion would be like in the US? In AUS the MIYA platform appears to be a unique product. Does anyone know if this is also the case for the US?
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game